Le Lézard
Classified in: Health, Business
Subjects: PDT, CXP

Gerresheimer Opens Glass Innovation and Technology Center in the U.S.


DUSSELDORF, Germany and VINELAND, New Jersey, Oct. 7, 2019 /PRNewswire/ -- Gerresheimer is driving innovation in pharmaceutical glass, primary packaging glass products, technologies and digitized processes. In the future, highly qualified engineers at the recently opened "Gx Glass Innovation and Technology Center" will develop innovative solutions for the pharmaceutical sector that meet today's and future demand of the pharma industry. During a customer event with more than 100 participants the CEO Dietmar Siemssen opened the new innovation center in Vineland, New Jersey, US.

"We are leading in health and well-being delivery. We are developing first-class glass solutions to meet highest quality requirements. In our new innovation center we will bundle our glass expertise and all our experts to develop new products and technologies, together with our customers in one place. Among those enhanced value propositions for our customers are Gx Elite Glass, ready-to-fill vials, strengthened glass and much more to come," said Dietmar Siemssen, CEO of Gerresheimer AG, in his opening speech at the new Gx Glass Innovation and Technology Center.

Gerresheimer has made significant investments in its production sites in the Americas over the past few years. In the Gx Glass Innovation and Technology Center, the company will intensify glass innovations as well as optimize all its processes to enable the Gerresheimer plants worldwide to make pharmaceutical glass of the highest quality. The team will work on new products, further digitization, process capabilities, camera inspection systems and much more.

Pooled development capacity

There are clear benefits to pooling development capacity at a single site: 25 experts and engineers specialized in glass technology will work together on innovation in a setting that is conducive to collaboration thanks to an open-plan office, project and meeting rooms, allowing interactive co-working with customers onsite. The innovation center is the first of its kind for Gerresheimer Primary Packaging Glass and was recently built next to the tubular glass converting plant in Vineland. Thereby the innovation center can develop new products and processes very close to a production site, involving the operational expertise of the engineers at that plant.

Image material is available directly from our homepage. High-resolution files also available on request. Printing free of charge; please provide a specimen copy. © Gerresheimer AG

Gerresheimer AG
Klaus-Bungert-Strasse 4
40468 Düsseldorf
Germany

Jens Kürten
Group Senior Director Communication & Marketing
Phone: +49-211-6181-250
Fax: +49-211-6181-241
E-mail: [email protected]  
Website: www.gerresheimer.com

 

SOURCE Gerresheimer AG


These press releases may also interest you

at 00:25
Shanghai Junshi Biosciences Co., Ltd ("Junshi Biosciences," HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced its financial...

28 mar 2024
The report titled "Central Lab Market by Service Type (Anatomic Pathology/Histology, Biomarker Services, Genetic Services), Phase (Phase 1, Phase 2, Phase 3), Therapeutic Area, End-use - Global Forecast 2024-2030" is now available on...

28 mar 2024
The report titled "Personalized Nutrition Market by Measurement Type (Active Measurement, Standard Measurement), Application (Indication-based, Standard Supplements), Distribution Channel, End-Use - Global Forecast 2024-2030" is now available on...

28 mar 2024
The report titled "Carbon Dioxide Incubator Market by Product (Air Jacketed CO2 Incubators, Direct Heat CO2 Incubators, Water Jacketed CO2 Incubators), Capacity (100-200 Litre, Above 200 Litre, Below 100 Litre), Application, End User - Global...

28 mar 2024
The "Global Clinical In Vitro Diagnostic Medical Laboratory Services Market: Strategy & Trends with Volume & Price Forecasts by Chemistry, Hematology, Microbiology, Pathology, Covid-19, and Molecular Dx by Country. Updated with Impact of COVID-19"...

28 mar 2024
The "Molecular Diagnostics at the Point of Care. By Application, Technology, Place, Product and by Country. With Executive Guides and Customization 2023 - 2027 " report has been added to  ResearchAndMarkets.com's offering. Infectious disease Dx is...



News published on and distributed by: